Skip to content

My Calendar

Events in May 2022

  • 2022 Bloom Burton & Co. Healthcare Investor Conference

    2022 Bloom Burton & Co. Healthcare Investor Conference

    All day
    May 2, 2022 May 3, 2022

    Bloom Burton is hosting its annual Bloom Burton & Co. Healthcare Investor Conference at the Metro Toronto Convention Centre (North Building) on May 2-3, 2022. We have invited 66 of Canada’s premier publicly-traded and venture-sponsored private companies to present to our audience, while hundreds of Canadian, U.S. and International investors attend to hear the latest developments in the Canadian healthcare industry.

    More information

  • 2022 Bloom Burton & Co. Healthcare Investor Conference

    2022 Bloom Burton & Co. Healthcare Investor Conference

    All day
    May 2, 2022 May 3, 2022

    Bloom Burton is hosting its annual Bloom Burton & Co. Healthcare Investor Conference at the Metro Toronto Convention Centre (North Building) on May 2-3, 2022. We have invited 66 of Canada’s premier publicly-traded and venture-sponsored private companies to present to our audience, while hundreds of Canadian, U.S. and International investors attend to hear the latest developments in the Canadian healthcare industry.

    More information

  • Pitching your innovation: Pro tips for scientists

    Pitching your innovation: Pro tips for scientists


    May 18, 2022

    NMIN Capacity-building Webinar

    Wednesday, May 18, 2022

    10:00 – 11:00 am (PDT) | 1:00 – 2:00 pm (EDT)

    Having a positive impact on society is the dream of many scientists. With a well-honed, understandable, and compelling pitch for your innovation, you can open doors to the partners who can help make those dreams come true.

    Clay Braziller, Visiting Lecturer at the Beedie School of Business at Simon Fraser University (SFU), will discuss how to communicate the potential impact of your innovation, how to bust the three mindsets that hold scientists back, and how to work through the seven elements of a simple pitch.

    This webinar will equally benefit the scientist who wants to move an innovation from the lab to the market, the institutional researcher looking for management support to continue their work, and the graduate looking for a new position.

    More information

  • From Candidates to Drugs – Applications of AI in Translational Research

    From Candidates to Drugs – Applications of AI in Translational Research


    May 25, 2022

    CQDM is proud to present a new series of webinars: The Evolving Landscape of AI Implementation in New Drug Discovery & Development.

    In the third event of the series Philip Tagari, VP of Research (Therapeutic Discovery), Amgen will host a panel of leading pharmaceutical and artificial intelligence executives to discuss the topic:

    From Candidates to Drugs – Applications of AI in Translational Research

    When? May 25th - 11h-12h30 EST.

    Please register ASAP and if you have specific questions on this topic please share them with us in advance

    More information

  • Pieter Cullis Invitational Lecture with Jean-​Christophe Leroux

    Pieter Cullis Invitational Lecture with Jean-​Christophe Leroux


    May 31, 2022

    What has gone wrong with publication practices?

    Tuesday 31 May 2022

    9-10:30 am PST | 12-1:30 pm EST

    Dr. Jean-​Christophe Leroux is Professor in Drug Formulation and Delivery at ETH Zurich. His research interests include the design of novel biopolymers, stimuli-​responsive drug delivery systems (liposomes, micelles and gels) and the targeting of anticancer drugs. Recently he has been involved in the development of polymer therapeutics for Celiac disease. He is the author or coauthor of numerous refereed articles, book chapters and patents/patent applications in the field of drug delivery. He serves in the editorial board of several journals including the Journal of Controlled Release and Molecular Pharmaceutics. He has received several prestigious distinctions and fellowships including the CRS-​Capsugel (1997 and 2003), AFPC-​Astra Zeneca (2003) and CRS young investigator awards (2004) and the Steacie Fellowships (2008) for innovative research in pharmaceutical technology.

    More information